The acute hemodynamic effects of intravenous verapamil in coronary artery disease. Assessment by equilibrium-gated radionuclide ventriculography
Journal Article
·
· Circulation; (United States)
The acute hemodynamic effects of an i.v. bolus of verapamil, 0.1 mg/kg or 0.06-0.075 mg/kg, were examined by serial radionuclide studies in 46 patients with coronary artery disease. In 20 patients with ejection fractions (EFs) greater than 35% (group 1A), verapamil, 0.1 mg/kg given over 1-11/2 minutes, had a biphasic effect: first, a transient decrease in EF accompanied by increased left ventricular (LV) volumes and cardiac output equivalents; then, an overshoot of EF to values above control, accompanied by a decrease in peripheral vascular resistance and a drastic decrease in LV volumes, while cardiac output equivalent remained slightly elevated. In eight patients with EFs less than 35% (group 1B), only the first effect on EF was noted. In 10 patients with EFs greater than 35% (group 2), verapamil, 0.06-0.075 mg/kg, exerted qualitatively similar but milder effects on hemodynamic function. Finally, verapamil, 0.1 mg/kg given more slowly, over 2-21/2 minutes, produced no significant changes in EF or LV volumes in another eight patients (group 3). The acute effects of verapamil are thus both time-related and dose-dependent. They are also related to the baseline functional reserve of the left ventricle. This study documents that verapamil exerts a depressant effect on LV function. However, the transient nature of this depression and the quick recovery to normal or above-normal values indicate that verapamil, in the doses used in this study, is safe to use intravenously in patients with coronary artery disease.
- Research Organization:
- Department of Cardiology, Meir General Hospital, Kfar-Saba, Israel
- OSTI ID:
- 6430722
- Journal Information:
- Circulation; (United States), Journal Name: Circulation; (United States) Vol. 67:1; ISSN CIRCA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Comparative effects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomized, crossover study with radionuclide ventriculography
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise
Journal Article
·
Wed Nov 30 23:00:00 EST 1983
· Circulation; (United States)
·
OSTI ID:6746854
Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function
Journal Article
·
Fri May 17 00:00:00 EDT 1985
· Am. J. Cardiol.; (United States)
·
OSTI ID:5078535
Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise
Journal Article
·
Tue Jun 01 00:00:00 EDT 1982
· Circulation; (United States)
·
OSTI ID:6816878
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
550901 -- Pathology-- Tracer Techniques
560306 -- Chemicals Metabolism & Toxicology-- Man-- (-1987)
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ARTERIES
BIOLOGICAL EFFECTS
BLOOD CIRCULATION
BLOOD VESSELS
BODY
CARDIOVASCULAR AGENTS
CARDIOVASCULAR SYSTEM
CORONARIES
DIAGNOSTIC USES
DISEASES
DRUGS
DYNAMIC FUNCTION STUDIES
HEART
LABELLED COMPOUNDS
ORGANS
PATIENTS
RADIOPHARMACEUTICALS
THERAPY
USES
VASCULAR DISEASES
VASODILATORS
550901 -- Pathology-- Tracer Techniques
560306 -- Chemicals Metabolism & Toxicology-- Man-- (-1987)
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ARTERIES
BIOLOGICAL EFFECTS
BLOOD CIRCULATION
BLOOD VESSELS
BODY
CARDIOVASCULAR AGENTS
CARDIOVASCULAR SYSTEM
CORONARIES
DIAGNOSTIC USES
DISEASES
DRUGS
DYNAMIC FUNCTION STUDIES
HEART
LABELLED COMPOUNDS
ORGANS
PATIENTS
RADIOPHARMACEUTICALS
THERAPY
USES
VASCULAR DISEASES
VASODILATORS